Astrazeneca
Latest news, explainers and analysis on Astrazeneca. Tracking 2 stories on Arth Vani.
Connected in the graph
Latest on Astrazeneca
AstraZeneca Shares Dip as Breast Cancer Drug Etcamah Fails Key Late-Stage Trial
AstraZeneca's breast cancer treatment, Etcamah, failed to meet its primary goal in a late-stage clinical trial when combined with palbociclib. The setback led to a decline in the company's US-listed shares during aftermarket trading.
AstraZeneca, Bristol Myers Squibb Reportedly Eyeing $400 Billion Merger Deal
UK pharmaceutical giant AstraZeneca and its US rival Bristol Myers Squibb are reportedly in discussions for a massive $400 billion merger. If realized, this megadeal would create one of the world's largest drugmakers, significantly reshaping the global pharmaceutical landscape.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.